We pride ourselves on our courage in pursuit of new scientific challenges and our willingness to take on novel, sometimes risky drug discovery research from which larger pharmaceutical companies may shy away.
We have a collegial environment that enables us to coordinate innovative experiments while not being afraid to try new things or to terminate programs that do not yield desired scientific results.
At Gliknik we are committed to scientific rigor in discovering and developing innovative biologics for individuals with autoimmune diseases and cancer.
The weekly average number of planned internal meetings at Gliknik is one.